SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018614
Filing Date
2023-11-09
Accepted
2023-11-09 16:52:31
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20230930x10q.htm   iXBRL 10-Q 1534862
2 EX-31.1 fencf-20230930xex31d1.htm EX-31.1 13962
3 EX-31.2 fencf-20230930xex31d2.htm EX-31.2 18474
4 EX-32.1 fencf-20230930xex32d1.htm EX-32.1 9375
5 EX-99.1 fencf-20230930xex99d1.htm EX-99.1 207992
6 GRAPHIC fencf-20230930xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-23-018614.txt   6899087

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20230930.xsd EX-101.SCH 46958
8 EX-101.CAL fencf-20230930_cal.xml EX-101.CAL 36621
9 EX-101.DEF fencf-20230930_def.xml EX-101.DEF 198052
10 EX-101.LAB fencf-20230930_lab.xml EX-101.LAB 323012
11 EX-101.PRE fencf-20230930_pre.xml EX-101.PRE 307853
54 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20230930x10q_htm.xml XML 1214029
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 231393437
SIC: 2836 Biological Products, (No Diagnostic Substances)